Everolimus-related organizing pneumonia: a report establishing causality

Invest New Drugs. 2012 Jun;30(3):1244-7. doi: 10.1007/s10637-010-9624-y. Epub 2010 Dec 29.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Everolimus
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Male
  • Pneumonia / chemically induced*
  • Pneumonia / diagnosis
  • Sirolimus / adverse effects
  • Sirolimus / analogs & derivatives*
  • TOR Serine-Threonine Kinases / antagonists & inhibitors

Substances

  • Immunosuppressive Agents
  • Everolimus
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • Sirolimus